We are live on ! Find out more
GHSI

Guardion Health Sciences, Inc. Common Stock

Delisted

GHSI was delisted on the 11th of October, 2024.

6 hedge funds and large institutions have $60K invested in Guardion Health Sciences, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more capital invested

Capital invested by funds: $18K → $60K (+$42K)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

50% more funds holding

Funds holding: 46 (+2)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VF
1
Virtu Financial
New York
$26K +$25.8K +114 New
TSS
2
Two Sigma Securities
New York
$19K +$18.8K +83 New
HF
3
HRT Financial
New York
$9K +$9.51K +42 New
UBS Group
4
UBS Group
Switzerland
$6K +$6.34K +28 New
Citadel Advisors
5
Citadel Advisors
Florida
-$14K -38 Closed
TRCT
6
Tower Research Capital (TRC)
New York
-$3K -8 Closed
Victory Capital Management
7
Victory Capital Management
Texas
+$226 +1 New

GHSI Hedge Fund Activity: Q3 2019 in Review

6 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q3 2019, worth a combined $60K — up 233% from $18K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new GHSI positions and 3 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $25.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $14K sold.

  • 6 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q3 2019, up from 4 in Q2 2019.
  • Funds reported $60K of Guardion Health Sciences, Inc. Common Stock stock for Q3 2019, up 233% quarter-over-quarter.
  • 5 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q3 2019 and 3 closed out, a net change of +2 holders.
  • The largest Guardion Health Sciences, Inc. Common Stock buyer in Q3 2019 was Virtu Financial, an estimated $25.8K added.
  • The largest Guardion Health Sciences, Inc. Common Stock seller in Q3 2019 was Citadel Advisors, an estimated $14K sold.

Based on aggregated 13F filings for Q3 2019.